With the continuing pressures on the National Drugs Budget, comes a wider and ongoing issue. Inequality of access to care & medication is routinely experienced by patients across many therapy areas. To facilitate a discussion on how this is impacting patient care, the PMI are bringing together an expert panel to discuss the consequences of this
inequity – both now and into the future.
